Critical tests and safety studies on a levamisole-piperazine mixture as an anthelmintic in the horse.
D000284:Administration, Oral; D000818:Animals; D002590:Cestode Infections / Q000188:drug therapy / Q000662:veterinary; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006374:Helminthiasis, Animal; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D007978:Levamisole / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D009198:Myiasis / Q000188:drug therapy; D009349:Nematode Infections / Q000188:drug therapy / Q000662:veterinary; D010123:Oxyuriasis / Q000188:drug therapy / Q000662:veterinary; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D017205:Spirurida Infections / Q000188:drug therapy / Q000662:veterinary; D013319:Strongyle Infections, Equine / Q000188:drug therapy
D010879:Piperazines; D007978:Levamisole